登录 注册 会员服务 联系我们

Infliximab-induced cutaneous eruption resembling pityriasis rubra pilaris in a patient with Takayasu's arteritis

  • Published:2016-11-12 Issue:3 Volume:30 Page:e12443
  • ISSN:1396-0296
  • Container-title:Dermatologic Therapy
  • language:en
  • Short-container-title:Dermatologic Therapy

Author:

Salman Andac1,Sonmez Yaman1,Sahin Hulya2,Unal Ali Ugur3,Direskeneli Haner3,Cinel Leyla2,Ergun Tulin1

Affiliation:

1. Department of Dermatology; Marmara University School of Medicine; Istanbul Turkey

2. Department of Pathology; Marmara University School of Medicine; Istanbul Turkey

3. Divison of Rheumatology; Marmara University School of Medicine; Istanbul Turkey

Publisher

Wiley

Subject

Dermatology,General Medicine

Reference9 articles.

1. Treatment of refractory adult-onset pityriasis rubra pilaris with TNF-alpha antagonists: A case series;Garcovich;Journal of the European Academy of Dermatology and Venereology,2010

2. Broad range of adverse cutaneous eruptions in patients on TNF-alpha antagonists;Hawryluk;Journal of Cutaneous Pathology,2012

3. Pityriasis rubra pilaris-like eruption associated with the multikinase inhibitor ponatinib;Jack;Journal of the American Academy of Dermatology,2013

4. Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease;Mocci;Journal of Crohn's and Colitis,2013

5. Sorafenib-induced eruption resembling pityriasis rubra pilaris;Paz;Journal of the American Academy of Dermatology,2011

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Role of Biologic Drugs Targeting IL-17 and IL-23: Pityriasis Rubra Pilaris;Life;2024-07-24

2. Drugs associated with development of pityriasis rubra pilaris: A systematic review;Journal of the American Academy of Dermatology;2021-04

3. Biologics for pityriasis rubra pilaris treatment: A review of the literature;Journal of the American Academy of Dermatology;2018-08

4. A Review on Pityriasis Rubra Pilaris;American Journal of Clinical Dermatology;2018-01-04

5. Infliximab;Reactions Weekly;2017-07
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3